Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Hairong Tian"'
1
Akademický článek
The role of complement factor H in gestational diabetes mellitus and pregnancy
Autor: Junxian Li, Ying Shen, Hairong Tian, Shuting Xie, Ye Ji, Ziyun Li, Junxi Lu, Huijuan Lu, Bo Liu, Fang Liu
Publikováno v: BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Complement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mel
Externí odkaz: https://doaj.org/article/e5fb693f1c2c412481ec6b8b961d6106
Zobrazit plný text záznamu
2
Akademický článek
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study
Autor: Peiliang Wang, Xiaozhuang Fang, Tianwen Yin, Hairong Tian, Jinming Yu, Feifei Teng
Publikováno v: Frontiers in Oncology, Vol 11 (2021)
BackgroundPre-clinical and clinical evidences support that simultaneous blockade of programmed death-1 (PD-1) and vascular endothelial growth factor receptor (VEGFR) can enhance antigen-specific T-cell migration, and show tolerable toxicity with favo
Externí odkaz: https://doaj.org/article/17799ffe3660403a86905eb65e9b7002
Zobrazit plný text záznamu
3
Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
Autor: Yaru, Tian, Hairong, Tian, Xiaoyang, Zhai, Hui, Zhu, Jinming, Yu
Publikováno v: Frontiers of Medicine. 16:610-617
Bevacizumab, an anti-VEGF monoclonal antibody, has significantly improved the clinical outcomes of patients with advanced non-squamous NSCLC (ns-NSCLC). However, the safety and efficacy of bevacizumab for elderly patients with advanced NSCLC require
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49bb216959f514f219248bad0d3e1d8
https://doi.org/10.1007/s11684-021-0827-8
Zobrazit plný text záznamu
4
High level of complement factor Ba within first prenatal test of gestation increases the risk of subsequent gestational diabetes: a propensity score-matched study
Autor: Junxi Lu, Junxian Li, Fang Liu, Ying Shen, Huijuan Lu, Ye Ji, Bo Liu, Hairong Tian, Ziyun Li
Publikováno v: Gynecological Endocrinology. 38:158-163
This study was to assess the alteration of circulating complement factor Ba (CFBa) within 11 to 17 weeks of gestation and its association with subsequent gestational diabetes mellitus (GDM) and its delivery outcome.Biochemical parameters and blood sa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5598dc976e3d3d6d9c63622184f887e
https://doi.org/10.1080/09513590.2021.1989400
Zobrazit plný text záznamu
5
The role of complement factor H in gestational diabetes mellitus and pregnancy
Autor: Fang Liu, Junxian Li, Junxi Lu, Huijuan Lu, Ziyun Li, Bo Liu, Ying Shen, Ye Ji, Hairong Tian, Shuting Xie
Publikováno v: BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Pregnancy and Childbirth
BackgroundComplement factor H (CFH) has been found to be associated with insulin resistance. This study assessed the correlation between CFH and other clinical parameters, and determined whether CFH played a role in gestational diabetes mellitus (GDM
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57558b15c9865d6b3a1bdc9da7d61f2b
https://doaj.org/article/e5fb693f1c2c412481ec6b8b961d6106
Zobrazit plný text záznamu
6
High Level of Complement Factor Ba Within 11 to 17 Weeks of Gestation Increases the Risk of Subsequent Gestational Diabetes: A Propensity Score-Matched Study
Autor: Ying Shen, Junxi Lu, Ziyun Li, Hairong Tian, Fang Liu, Junxian Li, Huijuan Lu, Ye Ji, Bo Liu
Background: Several studies have shown that the over activation of complement factor B(CFB) was related to obesity, insulin resistance(IR) and type 2 diabetes mellitus. This study was to assess whether circulating complement factor Ba (CFBa) within 1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::575999c04adaa1012e9b8e95a7e16253
https://doi.org/10.21203/rs.3.rs-150353/v1
Zobrazit plný text záznamu
7
Akademický článek
Strategies to inTerrupt RAbies Transmission for the Elimination Goal by 2030 In China (STRATEGIC): a modelling study.
Autor: Chen, Qiulan1 (AUTHOR), Liu, Qiuping2 (AUTHOR), Gong, Chao2 (AUTHOR), Yin, Wenwu1 (AUTHOR), Mu, Di1 (AUTHOR), Li, Yu1 (AUTHOR), Ding, Shujun3 (AUTHOR), Liu, Yifang4 (AUTHOR), Yang, Hao5 (AUTHOR), Zhou, Shuwu6 (AUTHOR), Chen, Sa7 (AUTHOR), Tao, Zhongfa8 (AUTHOR), Zhang, Yanping1 (AUTHOR) zhangyp@chinacdc.cn, Tang, Xun2 (AUTHOR) tangxun@bjmu.edu.cn
Publikováno v: BMC Medicine. 3/16/2023, Vol. 21 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu
8
Akademický článek
High level of complement factor Ba within first prenatal test of gestation increases the risk of subsequent gestational diabetes: a propensity score-matched study.
Autor: Shen, Ying1 (AUTHOR), Li, Junxian2 (AUTHOR), Tian, Hairong3 (AUTHOR), Ji, Ye3 (AUTHOR), Li, Ziyun3 (AUTHOR), Lu, Junxi4 (AUTHOR), Lu, Huijuan4 (AUTHOR), Liu, Bo3 (AUTHOR), Liu, Fang2,4 (AUTHOR)
Publikováno v: Gynecological Endocrinology. Feb 2022, Vol. 38 Issue 2, p158-163. 6p.
Zobrazit plný text záznamu
9
Akademický článek
The role of complement factor H in gestational diabetes mellitus and pregnancy.
Autor: Li, Junxian1, Shen, Ying2, Tian, Hairong3, Xie, Shuting1, Ji, Ye3, Li, Ziyun3, Lu, Junxi1, Lu, Huijuan1, Liu, Bo3, Liu, Fang1,4 f-liu@sjtu.edu.cn
Publikováno v: BMC Pregnancy & Childbirth. 8/17/2021, Vol. 21 Issue 1, p1-9. 9p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje